CEO CEO Transition CEO Appointment CEO Succession CFO Appointment CEO Resignation CEO Retirement Industry Experience CEO Decisions Joey Levin CEO Insights Cultural Institutions Alpine Talent Management Resignation Athletics Department Leadership Boeing 737 Program Disney Live-Action Chief Executive Officer Alessandro DiNello Chief Financial Officer Boeing CEO Credit Agreement Default CAG Leadership Changes CEO Replacement Non-Profit Sector Nonprofit Sector CEO Appointments Startups CEO Role Chief Commercial Officer CFO Transition David Duffy Communications Leadership Changes in Saks Global Impact on Companies Mike Abbott Corporate Governance
The company announces a €415.8 million net loss, lowers 2025 revenue forecast, and targets its first oncology approval by 2026.